相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hypophosphatemia after intravenous iron therapy: Comprehensive review of clinical findings and recommendations for management
Benedikt Schaefer et al.
BONE (2022)
Hypophosphataemia after treatment of iron deficiency with intravenous ferric carboxymaltose or iron isomaltoside-a systematic review and meta-analysis
Benedikt Schaefer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment
Seiji Fukumoto
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2021)
FGF23 at the crossroads of phosphate, iron economy and erythropoiesis
Daniel Edmonston et al.
NATURE REVIEWS NEPHROLOGY (2020)
Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia Two Randomized Clinical Trials
Myles Wolf et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia
Raj Amarnani et al.
RHEUMATOLOGY (2020)
Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review
John A. Glaspy et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2020)
Hypophosphataemia after ferric carboxymaltose is unrelated to symptoms, intestinal inflammation or vitamin D status
Wendy Fang et al.
BMC GASTROENTEROLOGY (2020)
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose
Giuseppe Rosano et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
Dieter Haffner et al.
NATURE REVIEWS NEPHROLOGY (2019)
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
Wendy Fang et al.
JGH OPEN (2019)
Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report
Johann Bartko et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Re: Hypophosphatemia, Severe Bone Pain, Gait Disturbance, and Fatigue Fractures After Iron Substitution in Inflammatory Bowel Disease: A Case Report
Symeon Tournis et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit
Tomas Urbina et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2018)
Methodological quality and synthesis of case series and case reports
Mohammad Hassan Murad et al.
BMJ EVIDENCE-BASED MEDICINE (2018)
Randomized trial of intravenous iron-induced hypophosphatemia
Myles Wolf et al.
JCI INSIGHT (2018)
Long-term iron polymaltose infusions associated with hypophosphataemic osteomalacia: a report of two cases and review of the literature
Ramy H. Bishay et al.
THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM (2017)
Blood and Bone Loser Symptomatic Hypophosphatemia and Osteomalacia With Bilateral Symmetric Pseudofractures
Benedikt Schaefer et al.
GASTROENTEROLOGY (2017)
A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome A case report
Hiroshi Nomoto et al.
MEDICINE (2017)
Iron-induced hypophosphatemia: an emerging complication
Heinz Zoller et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2017)
Drug-specific hypophosphatemia and hypersensitivity reactions following different intravenous iron infusions
Palle Bager et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2017)
Symptomatic hypophosphataemic osteomalacia secondary to the treatment with iron carboxymaltose detected in bone scintigraphy
M. J. Sangros Sahun et al.
REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR (2016)
Arthralgias and fractures in an adult male: Beyond hypovitaminosis D
Beatriz Tejera Segura et al.
MEDICINA CLINICA (2014)
Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women
Myles Wolf et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Fibroblast Growth Factor 23-Related Osteomalacia Caused by the Prolonged Administration of Saccharated Ferric Oxide
Sunao Yamamoto et al.
INTERNAL MEDICINE (2012)
The 2011 IOM Report on Vitamin D and Calcium Requirements for North America: Clinical Implications for Providers Treating Patients With Low Bone Mineral Density
Clifford J. Rosen et al.
JOURNAL OF CLINICAL DENSITOMETRY (2011)
Iron Modifies Plasma FGF23 Differently in Autosomal Dominant Hypophosphatemic Rickets and Healthy Humans
Erik A. Imel et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Hypophosphatemia induced by intravenous administration of saccharated ferric oxide Another form of FGF23-related hypophosphatemia
Yuichiro Shimizu et al.
BONE (2009)
FGF23 Elevation and Hypophosphatemia after Intravenous Iron Polymaltose: A Prospective Study
Belinda J. Schouten et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia
Belinda J. Schouten et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
分享论文
